As previously announced, VBI Vaccines Inc. (NASDAQ:VBIV) (“VBI”) and SciVac Therapeutics Inc. (TSX:VAC and OTCQX:SVACF) (“SciVac”) will host a joint conference call for their respective shareholders at 3:00 P.M. Eastern Time on Thursday, November 5th, 2015.
The call will include a live webcast and be hosted by Jeff Baxter, President and CEO of VBI, and Dr. Curtis Lockshin, CEO of SciVac, who will together discuss the previously announced entry into a merger agreement whereby, subject to the satisfaction of certain conditions, a wholly owned subsidiary of SciVac will merge with and into VBI, with VBI surviving as a wholly owned subsidiary of SciVac. The conference call will provide shareholders of VBI and SciVac with an opportunity to ask appropriate questions regarding the proposed merger.
Webcast and Conference Call Information
- When: Thursday, November 5th, 2015, 3:00 P.M. Eastern Time
- Conference Call: http://dpregister.com/10075803. Register to receive dial-in instructions.
- Webcast: http://services.choruscall.com/links/vbi-scivac151105. Allow at least ten minutes to access the site before the webcast begins.
VBI and SciVac will have posted prior to the conference call an investor presentation to accompany the conference call in the Investors sections of their respective websites.
For those shareholders unable to participate in the webcast or conference call, a transcript will be available on VBI’s website at www.vbivaccines.com and SciVac’s website at www.scivactherapeutics.com and will be filed with the U.S Securities and Exchange Commission by each of VBI and SciVac and available at www.sec.gov. Additionally, the webcast will be available for replay on VBI’s and SciVac’s respective websites for a period of 60 days.